Podcasts about cancer treatment

Over the last five years, billions of people have received at least one dose of a COVID-19 mRNA vaccine. New research has found an unanticipated result of these vaccines: Cancer treatments are more effective for some vaccinated patients, and many live longer than their unvaccinated counterparts. This news comes at a time where the federal government is slashing funding for mRNA research. Host Ira Flatow speaks to lead study author Adam Grippin and vaccine expert Eric Topol.Guests: Dr. Adam Grippin is a radiation oncologist at the MC Anderson Cancer Center in Houston, Texas. Dr. Eric Topol is a cardiologist and genomics professor at the Scripps Research Institute in La Jolla, California.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

In this deeply inspiring episode of Keeping Abreast, Dr. Jenn Simmons welcomes Dr. Pete Sulack—chiropractor, functional medicine practitioner, and founder of Unhealthy Anonymous—for a powerful conversation about defying the odds after a terminal cancer diagnosis.Dr. Sulack shares how he turned a death sentence into a journey of hope, healing, and renewal. Through faith, nutrition, and lifestyle transformation, he reclaimed his health and now guides others to do the same. Together, he and Dr. Jenn challenge conventional cancer paradigms, exploring how mindset, personalized nutrition, and spiritual alignment can unlock the body's innate capacity to heal.This episode invites listeners to rethink what's possible in cancer recovery and beyond. It's a story of courage, resilience, and faith in both science and spirit—reminding us that health is not something we outsource but something we build from within.In This Episode, You Will Learn:How Dr. Sulack overcame a terminal brain cancer diagnosisWhy functional medicine focuses on healing the whole person, not just treating diseaseThe crucial role of personalized nutrition in recoveryHow food sensitivities and gut health shape overall wellnessWhy conventional medicine often overlooks the importance of dietThe link between faith, mindset, and the body's innate ability to healHow to take proactive responsibility for your healthWhy empowerment and education can change the cancer care paradigm

Send us a textCould exercise be just what the doctor ordered for recovery during chemotherapy? In this episode of “The UMB Pulse,” explore this novel approach to cancer recovery with Ian Kleckner, PhD, MPH, associate professor at the University of Maryland School of Nursing and director of the SYNAPSE Center. Kleckner shares how exercise can alleviate symptoms of chemotherapy-induced peripheral neuropathy and improve the quality of life for cancer survivors. Through his research, Kleckner investigates how movement can reduce inflammation, enhance brain and body coordination, and empower patients to reclaim their lives. Chapter Markers 00:00 – Introduction 00:00:17 – Cancer Treatment & Neuropathy 00:01:37 – Guest Introduction: Dr. Ian Kleckner 00:05:06 – Understanding Neuropathy 00:09:38 – Research Findings: Brain & Exercise 00:13:33 – Exercise Intervention & Clinical Trials 00:19:08 – Practical Advice & Takeaways 00:23:31 – Conclusion & CreditsListen to The UMB Pulse on Apple, Spotify, Amazon Music, and wherever you like to listen. The UMB Pulse is also now on YouTube.Visit our website at umaryland.edu/pulse or email us at umbpulse@umaryland.edu.

Dr. Elias Sayour, a pediatric hematologist and oncologist, joins Lester Kiewit to discuss research suggesting that Pfizer and Moderna mRNA COVID-19 vaccines can enhance the effectiveness of immunotherapy in some cancer patients. Dr. Sayour explains that when administered within 100 days of starting checkpoint inhibitor treatment, the vaccines “act like a 911 siren,” mobilizing immune cells to better target tumors, with evidence observed across cancers including lung, melanoma, breast, and head and neck cancers. While the findings are retrospective and not yet definitive, Dr. Sayour highlights the potential for future trials and the broader promise of mRNA technology in cancer therapy, universal vaccines, and personalized immune responses. “Even if we run a phase three trial and it doesn’t work, it is my sincere belief that this idea holds merit,” he says. Good Morning Cape Town with Lester Kiewit is a podcast of the CapeTalk breakfast show. This programme is your authentic Cape Town wake-up call. Good Morning Cape Town with Lester Kiewit is informative, enlightening and accessible. The team’s ability to spot & share relevant and unusual stories make the programme inclusive and thought-provoking. Don’t miss the popular World View feature at 7:45am daily. Listen out for #LesterInYourLounge which is an outside broadcast – from the home of a listener in a different part of Cape Town - on the first Wednesday of every month. This show introduces you to interesting Capetonians as well as their favourite communities, habits, local personalities and neighbourhood news. Thank you for listening to a podcast from Good Morning Cape Town with Lester Kiewit. Listen live on Primedia+ weekdays between 06:00 and 09:00 (SA Time) to Good Morning CapeTalk with Lester Kiewit broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/xGkqLbT or find all the catch-up podcasts here https://buff.ly/f9Eeb7i Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567See omnystudio.com/listener for privacy information.

Dr. Stacy Lindborg, President and CEO of IMUNON, has developed a DNA-based immunotherapy candidate for the treatment of ovarian cancer. This therapy works by administering the drug, which utilizes IL-12, a powerful anti-cancer cytokine, directly into the cavity where the cancer resides, thereby affecting the tumor microenvironment. Trials are showing that the drug can produce significant life extension when used in combination with standard chemotherapy. Stacy explains, "There are about 300,000 women who are newly diagnosed with advanced ovarian cancer every year, about 20,000 in the US, and the frontline standard of care hasn't seen a change in the treatment in about 25 years. So this is for newly diagnosed women. The very first treatment that they would have, which we call frontline treatment, is a platinum-based chemotherapy. So carboplatin and Paclitaxel are both administered through IV over an hour for carboplatin, about three hours for Paclitaxel. So most women go directly to chemotherapy and then surgery, and then chemotherapy. Some women will go straight to surgery and then have this chemotherapy afterwards."   "Our approach is a DNA-based immunotherapy candidate that we have in Phase 3. We refer to the lead candidate as IMNN-001, and this is a non-viral nanoparticle that is administered directly into the cavity of interest. So, what we call the micro-tumor environment is the peritoneal cavity, where the cancer actually resides, and it's delivered through a catheter. And it basically has a very powerful anti-cancer fighting cytokine, IL-12, that is encoded in this immunotherapy. And it causes the cells that are within each woman's body, both cancer and non-cancer alike, to start producing activities that will help fight these complex cancer cells that exist."  #IMUNON #OvarianCancer #DNABasedImmunotherapy #WomensHealth #CancerAwareness  imunon.com Download the transcript here

Dr. Stacy Lindborg, President and CEO of IMUNON, has developed a DNA-based immunotherapy candidate for the treatment of ovarian cancer. This therapy works by administering the drug, which utilizes IL-12, a powerful anti-cancer cytokine, directly into the cavity where the cancer resides, thereby affecting the tumor microenvironment. Trials are showing that the drug can produce significant life extension when used in combination with standard chemotherapy. Stacy explains, "There are about 300,000 women who are newly diagnosed with advanced ovarian cancer every year, about 20,000 in the US, and the frontline standard of care hasn't seen a change in the treatment in about 25 years. So this is for newly diagnosed women. The very first treatment that they would have, which we call frontline treatment, is a platinum-based chemotherapy. So carboplatin and Paclitaxel are both administered through IV over an hour for carboplatin, about three hours for Paclitaxel. So most women go directly to chemotherapy and then surgery, and then chemotherapy. Some women will go straight to surgery and then have this chemotherapy afterwards."   "Our approach is a DNA-based immunotherapy candidate that we have in Phase 3. We refer to the lead candidate as IMNN-001, and this is a non-viral nanoparticle that is administered directly into the cavity of interest. So, what we call the micro-tumor environment is the peritoneal cavity, where the cancer actually resides, and it's delivered through a catheter. And it basically has a very powerful anti-cancer fighting cytokine, IL-12, that is encoded in this immunotherapy. And it causes the cells that are within each woman's body, both cancer and non-cancer alike, to start producing activities that will help fight these complex cancer cells that exist."  #IMUNON #OvarianCancer #DNABasedImmunotherapy #WomensHealth #CancerAwareness  imunon.com Listen to the podcast here

Today, People Before Profit TD Richard Boyd Barrett was welcomed back into the Dáil after recovering from throat cancer.He took the opportunity to call for cancer services to be properly resourced and supported in his first speech back.Richard joins Ciara Doherty in the studio to discuss.

Today's guest is Lashelle Scott, breast cancer survivor, advocate, and policy administrator. She champions awareness, equity, and legislation, serving as an ambassador for the Susan G. Komen Cener for Public Policy and the American Cancer Society.We talk about healthcare and the financial burdens placed on so many, policy changes that are worth fighting for, the importance of funding for research, and so much more.No matter what side of the political aisle you align with, the truth is that cancer treatments are expensive and something needs to change. Conversations like this are an important step, along with the work Lashelle and so many others are doing. Resources:Lashelle's Facebook: https://www.facebook.com/thefutureSenatorScottLashelle's Instagram: https://www.instagram.com/senatornorthstar2021/Lashelle's Email: the.hope.project.initiative@gmail.comFollow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com

Jim Foote, CEO and Founder of First Ascent Biomedical a pioneer in functional precision medicine (FPM) that aims to eliminate guesswork from cancer treatment. After losing his son to cancer, Jim left a career in cybersecurity to build a data-driven platform that combines AI, robotics and real-time tumour testing to help doctors choose the right therapy for each patient. In this episode, we explore how FPM differs from traditional genomics-only testing, why tumours can respond differently even with the same patient and how AI can support rather than replace clinicians in treatment decisions. Jim also shares the economic impact of ineffective therapies, the challenges of scaling regulatory innovation in oncology, and why the future of cancer care depends on personalisation at the  cellular level.Timestamps:[00:00:45] What Is Functional Precision Medicine?[00:02:00] Jim's Personal Journey from Tech to Healthcare[00:05:50] Overcoming Regulatory and Systemic Gatekeepers[00:08:13] From Reactive Care to Personalised Treatment[00:09:08] What Lab Findings Reveal about Cancer Cells[00:10:30] Why Genomics Alone Isn't Enough[00:12:03] AI as Decision Support Not a Decision Maker[00:15:55] Cancer in Younger Populations and Misconceptions[00:20:25] Reducing Cost and Waste in Cancer Treatment[00:26:34] What Success Really Means to Jim FooteConnect with Jim - https://www.linkedin.com/in/jim-foote/ Learn more about First Ascent Biomedical - https://www.linkedin.com/company/firstascentbio/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwalSubscribe to the Podcast

Receipt of an mRNA vaccine for Covid within 100 days of beginning immunotherapy for lung cancer or melanoma increased a person's survival likelihood by a factor of two or greater, a new study shows. Johns Hopkins mRNA expert Jeff Coller … Might mRNA vaccines replace chemotherapy for cancer treatment? Elizabeth Tracey reports Read More »

People with lung cancer or melanoma who were receiving immunotherapy and got a Covid vaccine within 100 days of initiating treatment saw dramatically improved survival compared to those folks who did not receive a vaccine, a new study shows. mRNA … The benefit of mRNA vaccines in cancer treatment is ongoing, Elizabeth Tracey reports Read More »

Hosted on Acast. See acast.com/privacy for more information.

Welcome back to Navigating Cancer TOGETHER! We're picking up right where we left off with the remarkable Peta-Ann Wood, a breast cancer thriver and Soulful Coach.Part 1, "Choosing Flat: Peta-Ann's Journey to Self-Acceptance," was about the courage to choose (flatness, self-advocacy, and leaving people-pleasing behind). Now, Part 2 is the roadmap for flourishing once those massive decisions are made.Peta-Ann opens up about the powerful shift from managing her life to becoming a Happiness Coach. She reveals how her personal journey, touching on her late AuDHD diagnosis and her life-affirming choice to go flat, gave her a unique lens for helping others find inner peace and contentment.If you are struggling with the transition after treatment ends, or if you feel like your self-worth took a hit during your diagnosis, this episode is dedicated to you. Peta-Ann shares candid advice and heartwarming success stories that prove recovery isn't just about survival, it's about building a happier life than you had before.✨Episode Highlights:03:36 Understanding the shift: Why Peta-Ann focused on Happiness Coaching.08:47 How Lived Experience fuels her personal growth and guidance.16:28 Navigating Cancer TOGETHER: A reflection on building genuine community support.26:49 Words of Encouragement: Direct, honest advice for the cancer community.Transcript: https://bit.ly/podscript175Part I: https://podcast.ausha.co/navigatingcancertogether/choosing-flat-peta-ann-s-journey-to-self-acceptanceConnect & Engage with Peta-Ann:Website: https://www.elegantrebelponders.comInstagram: https://www.instagram.com/elegant.rebel.pondersFacebook: https://www.facebook.com/ElegantRebel44Call to Action & Community:If Peta-Ann's adventure resonated with you, or you know someone else needs to hear this transformative conversation, please share this episode! Text the link to a fellow survivor, patient, or caregiver who could use a dose of guidance and hope today.Don't miss the next human-centered conversation! Subscribe or follow Navigating Cancer TOGETHER on your favorite podcast app or platform to ensure you get immediate alerts for every new episode.Join the Waitlist: Get ready to connect with a supportive community! Join the waitlist for our Navigating Cancer TOGETHER forum here: https://www.ontheotherside.life/forum-waitlistHosted, Produced, Written, and Edited by: Talaya DendyDisclaimer: The information on this podcast is for general informational purposes only and SHOULD NOT be used as a substitute for sound professional medical advice, evaluation, or care from your physician or other qualified health care provider.Hosted by Ausha. See ausha.co/privacy-policy for more information.

Here I explain the lymphatic system, a crucial bodily network for overall health and appearance. I explain how the lymphatic system works to remove cellular waste and fluid from your organs and combat infections. I provide science-based tools that support your lymphatic system for the sake of health and appearance, including: how to reduce fluid retention in your limbs, trunk or face, how to eliminate 'bags' under your eyes and brain fog, and how to improve cardiac health and longevity. Because your lymphatic system lacks a central pump, it needs the mechanical forces generated by specific types of bodily movement, breathing and pressure to circulate your lymph properly, and I explain how you can activate these. I also explain how to support optimal functioning of your glymphatic system, a brain- and spinal cord waste-clearing system active during sleep that is crucial for brain functioning and longevity, including to prevent dementia. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AGZ by AG1: https://drinkagz.com/huberman LMNT: https://drinklmnt.com/huberman David: https://davidprotein.com/huberman Eight Sleep: https://eightsleep.com/huberman Function: https://functionhealth.com/huberman Timestamps (00:00:00) Lymphatic System (00:04:11) Circulatory System, Heart; Oxygen, Nutrient & Waste Transfer (00:11:03) Lymphatic System, Fluid, Lymphedema, Chronic Inflammation; Brain Fog (00:14:52) Sponsor: LMNT & David Protein (00:17:28) Lymphatic Vessels, Tool: Enhance Lymphatic Drainage with Movement (00:26:24) Tools: Jumping (Rebounding), Treading Water, Swimming (00:27:41) Tool: Swelling, Lymphatic Drainage & Diaphragmatic Breathing (00:32:05) Swimming & Lymphatic Flow; Tai Chi (00:34:00) Lymphatic Massage, Cancer & Lymphedema; Jade Roller & Gua Sha (00:37:28) Sponsor: AGZ by AG1 (00:38:56) Lymph Flow, Tool: Lymphatic Massage & Manual Lymphatic Drainage (00:45:02) Immune Function of Lymphatic System, Sore Lymph Nodes (00:54:24) Cancer Treatment, Lymph Nodes & Lymphedema (00:57:02) Limb Swelling, Minor Lymphedema & Inflammation, Lymphatic Boots (01:00:09) Sponsors: Eight Sleep (01:01:43) Glymphatic System, Brain & Sleep (01:05:56) Sleep & Brain Waste Recycling; Discovery of the Glymphatic System (01:12:24) Enhance Glymphatic Clearance, Brain Fog, Age, Tool: Side Sleeping Position (01:15:54) Tools: Optimize Sleep, Cardiovascular Exercise, Elevate Feet, Pillow (01:17:29) Puffy Face, Tool: Lymphatic & Facial Massage (01:21:23) Sponsor: Function (01:23:11) Tool: Hydration & Lymphatic Support (01:24:48) Tool: Cardiovascular Exercise & Lymphatic Vessels, Heart, Aging (01:31:06) Tool: Infrared & Red Light, Mitochondria, Lymphedema, Skin Appearance (01:36:08) Key Takeaways (01:37:21) Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

It's a cancer treatment breakthrough that could save lives and doctors want it available to everyone.

It's a cancer treatment breakthrough that could save lives and doctors want it available to everyone.

Welcome to a special bonus episode of YXE Underground. My name is Eric Anderson and it has been a busy week for the podcast.Last Monday, I dropped an episode that took listeners to Beaver Creek Conservation Area to enjoy a Dark Skies event put on by the Meewasin Valley Authority.On Thursday, I spoke with Katayoon Navabi about the Diaspora Film Festival she was helping organize at the Remai Modern. I saw a great documentary yesterday as part of the film festival called Allihopa: The Dalkurd Story. My congrats to Katayoon and her team for putting on such a wonderful event. Today, I am sharing a conversation about an upcoming fundraising event that has raised more than three million dollars since 2007.Choc'la Cure is a non-profit organization dedicated to raising funds to purchase cancer treatment equipment used at the Saskaoon Cancer Centre. It formed 18 years ago and has impacted the lives of so many people in Saskatoon and throughout our province.Choc'la Cure's annual gala event takes place on November 7th at Dutch Growers, and I learned more about the organization and its impact on the Saskatoon Cancer Centre thanks to Kim Swiatecki, Breanne Cooper and Dr. John DeCoteau. Kim is a volunteer on the Choc'la Cure committee and a previous guest on the podcast way back in season one. Breanne is the Chair of Choc'la Cure, and Dr. DeCoteau is the Medical Director of the Advanced Diagnostic Research Lab at the Saskatoon Cancer Centre. The goal of this year's gala is to raise money for a new piece of medical equipment for the Cancer Centre, which Dr. DeCoteau explains in fascinating detail in our conversation. I met Kim, Breanne and Dr. DeCoteau at Citizen Café a few weeks ago and learned so much from all of them. Best of luck to the entire Choc'la Cure team on their upcoming fundraiser!Listen and follow YXE Underground wherever you find your favourite podcasts including Apple Podcasts, Spotify, and YouTube. Please feel free to leave a 5-star review if you enjoyed this episode. I would greatly appreciate it.Cheers...Eric      Host, Producer, Editor: Eric AndersonTheme Music: Andrew DicksonWebsite: https://www.yxeunderground.comRecorded: On Treaty 6 Territory and the traditional homeland of the Metis

TWiV explains studies showing that SARS-CoV-2 mRNA vaccines improve life span of cancer patients on checkpoint immunotherapy, and broad immunity conferred by a vaccine central in A(H5) influenza antigenic space. Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy Spindler Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV Immune 100 live at the Incubator SARS-CoV-2 mRNA vaccines sensitize tumors to checkpoint immunotherapy (Nature) People with some cancers live longer after mRNA vaccines (Nature) Immune checkpoint inhibitors (NCI) Broad immunity from influenza H5 vaccine (Nature) Derek Smith on antigenic cartography (TWiV 99 at 2:53) Letters read on TWiV 1265 Timestamps by Jolene Ramsey. Thanks! Weekly Picks Kathy – Permethrin-treated baby wraps for malaria prevention and Phil Sharp and the Biotech Revolution Rich – Lydia Fairchild; Tetragametic Chimerism (NEJM) Alan – Warning Signs Vincent – radio.garden thanks to Kim! Listener Pick Jamie – SkyCards by Flightradar24 Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

In this episode of Hashtag Trending, host Jim Love discusses the Canadian CIO of the Year Awards and recognizes several winners. Highlights include OpenAI entering the browser market with ChatGPT-integrated Atlas, posing a serious threat to Google Chrome's dominance. Security concerns with Atlas storing OAuth tokens are mentioned, urging caution while experimenting with new AI browsers. Additionally, the Glassworm malware hiding in Visual Studio Code extensions is detailed, highlighting the importance of auditing extensions. Finally, an AI model collaboration between Google and Yale University shows promising results in cancer treatment by making tumors more visible to the immune system. Tune in for these updates and more! 00:00 Shoutout to CIO Achievements 01:56 Introducing Hashtag Trending 02:02 OpenAI's New Browser: Atlas 04:14 Security Alert: Glass Worm in VS Code 06:37 AI Breakthrough in Cancer Treatment 08:25 Closing Remarks and How to Support Us

Prominent colorectal surgeon Frank Frizelle says it is now a necessity for dedicated cancer centres in New Zealand. The Christchurch-based surgeon believes if New Zealand does not adopt comprehensive cancer centres, the system will fail patients. Frizelle told Heather du Plessis-Allan, "it's just about trying to give adequate volumes and concentrations of resources to try and get the best value for money". LISTEN ABOVESee omnystudio.com/listener for privacy information.

In this honest and empowering episode of Navigating Cancer TOGETHER, host Talaya Dendy sits down with the phenomenal Peta-Ann Wood, breast cancer thriver, Soulful Coach, and creator of Elegant Rebel.This conversation goes beyond the clinical. Peta-Ann openly shares how a late diagnosis of AuDHD (Autism + ADHD) changed her cancer experience, guiding her from people-pleasing straight toward radical self-discovery.If you've ever felt pressure to make a decision about reconstruction, treatment, or even just how you should feel, this episode is your permission slip. Peta-Ann dives into the emotional process that led her to the definitive and life-changing choice to remain flat after her bilateral mastectomy.This is a must-listen for anyone in the cancer community who is questioning, redefining, or simply trying to prioritize their own needs and desires amidst the chaos of illness.✨Episode Highlights:02:21 Peta-Ann's Unique Journey: Navigating cancer alongside a late AuDHD diagnosis.07:40 The Shift: How life after diagnosis became about prioritizing her needs.12:23 Self-Advocacy Unlocked: Learning to trust intuition in a complex medical system.24:48 Beyond the Diagnosis: Understanding Neurodivergence and the End of People-Pleasing.29:40 The Definitive Choice: The transformative conversation about choosing to stay flat.38:35 Writing Her Truth: Insights into her book, What Happens When They Don't Go Back.Transcript: https://bit.ly/podscript174Connect & Engage with Peta-Ann:Website: https://www.elegantrebelponders.comInstagram: https://www.instagram.com/elegant.rebel.pondersFacebook: https://www.facebook.com/ElegantRebel44Resources & Call to Action:In honor of the movement: October 7th was International Flat Day, a global moment celebrating the beautiful choice of aesthetic flat closure. Learn more and connect: https://www.facebook.com/InternationalFLATDay/Connect with Your Community: Don't navigate this journey alone. Join the waitlist for our "Navigating Cancer TOGETHER" forum and connect with others who truly get it. https://www.ontheotherside.life/forum-waitlistSubscribe or follow Navigating Cancer TOGETHER on your favorite podcast app or platform so you never miss a vital conversation.Hosted, Produced, Written, and Edited by: Talaya DendyDisclaimer: The information on this podcast is for general informational purposes only and SHOULD NOT be used as a substitute for sound professional medical advice, evaluation, or care from your physician or other qualified health care provider.Hosted by Ausha. See ausha.co/privacy-policy for more information.

Pippa Hudson speaks to Samantha Loggenberg, who is a University of Pretoria PhD candidate, an is among eight female scientists awarded The L’Oréal-UNESCO For Women in Science Award for her investigation of South African medicinal plants to find new compounds that could help treat triple-negative breast cancer. Lunch with Pippa Hudson is CapeTalk’s mid-afternoon show. This 2-hour respite from hard news encourages the audience to take the time to explore, taste, read and reflect. The show - presented by former journalist, baker and water sports enthusiast Pippa Hudson - is unashamedly lifestyle driven. Popular features include a daily profile interview #OnTheCouch at 1:10pm. Consumer issues are in the spotlight every Wednesday while the team also unpacks all things related to health, wealth & the environment. Thank you for listening to a podcast from Lunch with Pippa Hudson Listen live on Primedia+ weekdays between 13:00 and 15:00 (SA Time) to Lunch with Pippa Hudson broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show, go to https://buff.ly/MdSlWEs or find all the catch-up podcasts here https://buff.ly/fDJWe69 Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

GT Biopharma (NASDAQ: GTBP) is pioneering a new era in cancer treatment: one that replaces cutting, burning, and poisoning with precision, safety, and the power of the body's own immune system.In this interview, Executive Chairman & CEO Michael Breen and Consulting Senior Medical Director Dr. Jeffrey Miller discuss how GT Biopharma's TriKE® technology harnesses natural killer (NK) cells to target and destroy cancer cells, offering a more humane alternative to traditional therapies. They talk about the science behind their platform, the progress of ongoing Phase 1 clinical trials for blood cancer, upcoming FDA filings for solid tumors, and how next-generation nanobody and camelid technology is advancing efficacy and safety.Discover why GT Biopharma's platform represents one of the most promising innovations in immunotherapy and why investors are watching closely as key data milestones approach.Learn more about GT Biopharma: https://www.gtbiopharma.com/Watch the full YouTube interview here: https://youtu.be/he9i0aJQ2JMAnd follow us to stay updated: https://www.youtube.com/@GlobalOneMedia

Rachel Cliffe, Community Outreach and Partnerships Manager at Siteman Cancer Center, discusses her role in cancer prevention and community education. She highlights the importance of healthy habits like eating well, exercising, and avoiding smoking to reduce cancer risk. Rachel shares her experience with recent partnerships with local businesses in St. Louis to help raise cancer awareness. Check out St. Louis Mom's latest reel of Ovarian Cancer Prevention in partnership with Siteman Cancer Center!This podcast episode is sponsored by Siteman Cancer Center: National Leaders in Cancer Treatment & Research.Rachel Cliffe is a Telly Award–winning producer at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, where she's spent seven years advancing the organization's mission to educate and empower the St. Louis community on cancer prevention and early detection. As Community Outreach & Partnerships Manager, Rachel develops innovative collaborations with local organizations, businesses, venues, and community groups to promote healthier lifestyles and raise awareness about the critical importance of early and routine cancer screenings. She also leads production of Siteman's award-winning podcast, ‘This Is Cancer', a patient-centered series featuring conversations with WashU Medicine physicians that aim to inform, uplift, and support individuals navigating cancer treatment, caregiving, and beyond. Outside of work, Rachel enjoys taking her kids to local parks, cooking, spending time with friends and family, and discovering new restaurants in St. Louis.We hope you enjoyed this podcast episode! To learn more about Moms of the Lou you can go to stlouismom.com or follow us on Instagram and Facebook. You can listen to the podcast on Apple Podcast and Spotify. And don't forget to rate and review so more people can tune in! This episode was produced by the St. Louis Mom. It was recorded and edited by STL Bucketlist Studios in St. Louis, Missouri. 

Dr. Patrick Quillin explores Nutrition 5.0, an innovative approach that places diet at the forefront of cancer therapy. Discover scientifically validated dietary strategies that enhance treatment outcomes, improve quality of life, and support long-term recovery. #CancerNutrition #IntegrativeHealth #HealingFoods

The advent of artificial light is obliterating women's moon-driven menstrual cycle rhythms; When the triple whammy of cataracts, glaucoma, and macular degeneration strikes; Why can systolic blood pressure spike erratically? Are wrist and finger wearables for blood pressure ready for prime time? Nearly half of drivers killed in crashes have THC in their blood; Drinking bottled water causes surge in plastic micro-particle intake; The common supplement that can supercharge cancer immunotherapy.

TALK ME OUT OF IT UPDATE: I Need To Borrow From My Friend's Cancer Treatment Fund full 256 Mon, 13 Oct 2025 13:57:24 +0000 kOCqRX74U1vj5I8qABJ7g9ByZlQjSQpb advice,kramer and jess,talk me out of it update,moral dilemma,music,society & culture,news Kramer & Jess On Demand Podcast advice,kramer and jess,talk me out of it update,moral dilemma,music,society & culture,news TALK ME OUT OF IT UPDATE: I Need To Borrow From My Friend's Cancer Treatment Fund Highlights from the Kramer & Jess Show. 2024 © 2021 Audacy, Inc. Music Society & Culture News False https://pla

Clinical trials pave the way for new breast cancer treatments, but many patients hesitate to take part. Dr. Elkhanany breaks down what these studies really mean and why access and education make a difference. What clinical trials are and how they work for patients Why every standard medicine starts with a trial How learning and access change treatment for everyone Key Questions Answered What is a clinical trial? Why do we need clinical trials? How do clinical trials progress from phase one to phase four? Why is it often difficult to get people to participate in clinical trials? How do you address patient skepticism towards clinical trials? Who decides if a new drug’s benefit is worth its risks? How do drug approval processes in the United States differ from those in Europe? What are the potential benefits for patients who participate in clinical trials? How do you approach a patient when recommending a clinical trial, especially if standard treatments have failed? What support systems exist to help patients participate in clinical trials, especially those traveling long distances or facing financial barriers? Timestamped Overview 00:00 Understanding Clinical Trials Stages 06:10 Advancing Medicine Through Clinical Trials 07:49 Cancer Treatment Decision Challenges 12:03 Global Drug Trial Decision Process 16:31 Immunotherapy Breakthrough in Cancer Treatment 20:10 Clinical Trials: Challenges and Importance 23:52 Key Patient Advice: Second Opinions 26:01 Bridging Clinical Trial Accessibility 29:05 Advancements Reducing Breast Cancer Mortality Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts.See omnystudio.com/listener for privacy information.

Clinical trials pave the way for new breast cancer treatments, but many patients hesitate to take part. Dr. Ahmed Elkhanany returns to the show to break down what these studies really mean and why access and education make a difference. What clinical trials are and how they work for patients Why every standard medicine starts with a trial How learning and access change treatment for everyone Key Questions Answered What is a clinical trial? Why do we need clinical trials? How do clinical trials progress from phase one to phase four? Why is it often difficult to get people to participate in clinical trials? How do you address patient skepticism towards clinical trials? Who decides if a new drug’s benefit is worth its risks? How do drug approval processes in the United States differ from those in Europe? What are the potential benefits for patients who participate in clinical trials? How do you approach a patient when recommending a clinical trial, especially if standard treatments have failed? What support systems exist to help patients participate in clinical trials, especially those traveling long distances or facing financial barriers? Timestamped Overview 00:00 Understanding Clinical Trials Stages 06:10 Advancing Medicine Through Clinical Trials 07:49 Cancer Treatment Decision Challenges 12:03 Global Drug Trial Decision Process 16:31 Immunotherapy Breakthrough in Cancer Treatment 20:10 Clinical Trials: Challenges and Importance 23:52 Key Patient Advice: Second Opinions 26:01 Bridging Clinical Trial Accessibility 29:05 Advancements Reducing Breast Cancer Mortality Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts.See omnystudio.com/listener for privacy information.

AI Therapy: Can An Algorithm Help You More Than A Human? Will AI therapy promote even more isolation within society? Dr. Michael Heinz, a research psychiatrist, is part of a team using generative AI to act as a therapist for people with anxiety, depression, and eating disorders. Dr. Michael Heinz explains how this always-available AI therapist measures up to human-based therapy, and how AI best fits into the future of mental health.' Segment 2: CAR-T Cell Therapy: Pioneering The Future Of Cancer Treatment CAR T-cell therapy is a groundbreaking cancer treatment that reprograms a patient's own immune cells to recognize and destroy cancer. First approved by the FDA in 2017, it's already shown success in patients with blood cancers that no longer respond to standard treatments. While the therapy can cause serious side effects, our expert this week –a pioneer of this therapy– discusses the future of using this powerful new weapon against cancer. Learn more about your ad choices. Visit megaphone.fm/adchoices

TRENDING - President Trump's doctor says he's in “exceptional” shape after his second presidential physical exam, while former President Joe Biden reveals he's undergoing radiation treatment for prostate cancer. We also remember Oscar-winning actress Diane Keaton, who has died at 79, and parents in Florida are outraged after a convicted child killer moved in next to an elementary school.See omnystudio.com/listener for privacy information.

In this edition of the Love In Action Podcast, Ken shares how Jesus gave him so much peace and joy while going through 36 radiation treatments for prostate cancer.

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world. ##FDA Approves New Cancer TreatmentThe FDA has approved a new cancer treatment that has shown promising results in clinical trials. This treatment is expected to provide a new option for patients who have not responded well to traditional therapies. ##Drug Company Announces Major Breakthrough in Alzheimer's ResearchA drug company has announced a major breakthrough in Alzheimer's research, with a new drug that has shown significant improvement in cognitive function in patients with the disease. This breakthrough could potentially change the way Alzheimer's is treated in the future. ##Biotech Startup Raises $50 Million in FundingA biotech startup has raised $50 million in funding to further develop its innovative technology. This funding will allow the company to continue its research and development efforts, with the goal of bringing new treatments to market. ##Pharma Company Expands Manufacturing FacilitiesA pharmaceutical company has announced plans to expand its manufacturing facilities in order to meet growing demand for its products. This expansion will create new jobs and increase production capacity, allowing the company to better serve its customers. ##New Study Shows Promising Results for Diabetes TreatmentA new study has shown promising results for a potential new treatment for diabetes. The treatment, which targets a specific pathway in the body, has shown significant improvements in blood sugar levels and insulin sensitivity in patients with type 2 diabetes. ##Biotech Company Collaborates with Research Institute on Rare Disease TreatmentA biotech company has announced a collaboration with a research institute to develop a new treatment for a rare disease. This partnership brings together expertise from both organizations to work towards finding a cure for this debilitating condition. ##FDA Issues Warning About Counterfeit DrugsThe FDA has issued a warning about counterfeit drugs being sold online. These drugs may not contain the proper ingredients or may be contaminated, posing serious risks to consumers who purchase them. It's important to only buy medications from reputable sources to ensure safety and effectiveness.Support the show

TRENDING - President Trump's doctor says he's in “exceptional” shape after his second presidential physical exam, while former President Joe Biden reveals he's undergoing radiation treatment for prostate cancer. We also remember Oscar-winning actress Diane Keaton, who has died at 79, and parents in Florida are outraged after a convicted child killer moved in next to an elementary school.

CAR T-cell therapy is a groundbreaking cancer treatment that reprograms a patient's own immune cells to recognize and destroy cancer. First approved by the FDA in 2017, it's already shown success in patients with blood cancers that no longer respond to standard treatments. While the therapy can cause serious side effects, our expert this week –a pioneer of this therapy– discusses the future of using this powerful new weapon against cancer. Learn more about your ad choices. Visit megaphone.fm/adchoices

Managing Mental Health & Social Challenges After Cancer Treatment with guest Dr. Nancy Borstelmann October 12, 2025 Yale Cancer Center visit: https://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Feeling tired, dizzy, or just "off" during cancer treatment? It might not just be the meds - dehydration can seriously affect your recovery. Learn what to watch for and what to do about it. https://bit.ly/4nPAOv0Why Is Dehydration a Threat for Persons with Cancer? Dehydration isn't just about feeling thirsty-it can seriously impact your cancer treatment, increase side effects, and even become life-threatening if left unaddressed. In this episode, we break down why people living with cancer are at higher risk for dehydration, how to recognize early warning signs, and simple but powerful ways to stay safely hydrated. Whether you're going through treatment or supporting someone who is, this is vital information you can't afford to miss.

TALK ME OUT OF IT: I Need To Borrow From My Friend's Cancer Treatment Fund full 772 Thu, 09 Oct 2025 14:29:19 +0000 sTc8x0TldfArhpq740obzL5KwfoPK8Yi advice,talk me out of it,borrow money,moral dilemma,music,society & culture,news Kramer & Jess On Demand Podcast advice,talk me out of it,borrow money,moral dilemma,music,society & culture,news TALK ME OUT OF IT: I Need To Borrow From My Friend's Cancer Treatment Fund Highlights from the Kramer & Jess Show. 2024 © 2021 Audacy, Inc. Music Society & Culture News False https://player.amp

Southwest Michigan's Morning News podcast is prepared and delivered by the WSJM Newsroom. For these stories and more, visit https://www.wsjm.com and follow us for updates on Facebook. See omnystudio.com/listener for privacy information.

In this episode of Disruption/Interruption, host KJ sits down with Jim Foote, CEO and founder of First Ascent Biomedical. Jim shares his personal journey from technology executive to cancer care innovator, after his son’s diagnosis changed his life. Discover how he’s disrupting the status quo in oncology with AI-driven, personalized medicine that’s giving new hope to patients and families. Key Takeaways: The Problem with Standard Cancer Care [3:53]The standard of care treats patients as if they are the same, but everyone is unique. This approach works two-thirds of the time, but leaves one-third of patients with few options. Functional Precision Medicine [13:04]Jim’s company tests up to 152 FDA-approved drugs on a patient’s biopsy to find the most effective treatment, providing doctors with data-driven options tailored to each individual. AI and Technology are Transforming Oncology [28:05]Advances in AI, robotics, and cloud computing have converged, making personalized cancer treatment faster, more affordable, and more effective than ever before. Impact and Future Vision [26:51]Jim’s goal is for every cancer patient to receive individualized treatment from the moment of diagnosis, improving outcomes and reducing unnecessary side effects. Quote of the Show (14:40):“I literally have gone from trying and hoping to testing and choosing.” — Jim Foote Join our Anti-PR newsletter where we’re keeping a watchful and clever eye on PR trends, PR fails, and interesting news in tech so you don't have to. You're welcome. Want PR that actually matters? Get 30 minutes of expert advice in a fast-paced, zero-nonsense session from Karla Jo Helms, a veteran Crisis PR and Anti-PR Strategist who knows how to tell your story in the best possible light and get the exposure you need to disrupt your industry. Click here to book your call: https://info.jotopr.com/free-anti-pr-eval Ways to connect with Jim Foote: LinkedIn: http://www.linkedin.com/in/jim-foote Company Website: https://firstascentbiomedical.com/ How to get more Disruption/Interruption: Amazon Music - https://music.amazon.com/podcasts/eccda84d-4d5b-4c52-ba54-7fd8af3cbe87/disruption-interruption Apple Podcast - https://podcasts.apple.com/us/podcast/disruption-interruption/id1581985755 Spotify - https://open.spotify.com/show/6yGSwcSp8J354awJkCmJlDSee omnystudio.com/listener for privacy information.

Zulma Williams: Inspiring Cancer Survivors Through Advocacy and Tenacity In this inspiring and essential episode of Navigating Cancer TOGETHER, host Talaya Dendy welcomes special guest Zulma Williams, a licensed clinical social worker and inspiring breast cancer survivor.Zulma shares her compelling personal journey: from immigrating to the U.S. and pursuing higher education later in life, to her personal journey through breast cancer treatment and recovery.This conversation is a vital resource for anyone facing a health challenge, focusing on the critical role of the patient.In this episode, you will gain crucial insights on:Self-Advocacy: Why being an informed and proactive patient is the most important step in your healthcare journey.Mental Well-being: Zulma's expertise on navigating anxiety, depression, and shared trauma during and after treatment.The Power of Attitude: Advice on setting boundaries, prioritizing self-care, and maintaining a positive mindset through life-altering challenges.Zulma's story and clinical experience blend to offer a powerful message of hope, tenacity, and authenticity. Don't miss her actionable advice on finding your voice and transforming your experience into a source of strength.✨Episode Highlights:08:50 Zulma's Breast Cancer Diagnosis and Treatment Journey20:38 KEY TOPIC: The Paramount Importance of Self-Advocacy in Healthcare30:55 Zulma's Insights: Addressing Anxiety, Depression, and Trauma in Recovery36:44 Practical Tips: Setting Boundaries and Prioritizing Self-Care38:25The Power of Attitude and Affirmations in Healing56:35Discussing Cultural Perspectives on Illness and Seeking TherapyTranscript: https://bit.ly/podscript173Connect & Engage with Zulma:Website & podcast: https://www.dragonflytherapyservices.netInstagram: https://www.instagram.com/theswearingtherapist/Connect with NCT: nctpodcastfan@gmail.com, https://fanlist.com/nctpodcastSupport the new Survivor Series: A mission to uncover the unfiltered reality of survivorship. Learn more here: https://givebutter.com/SurvivorSerieswithTalayaDendyNavigating Cancer TOGETHER delivers heartfelt stories and expert insights to remind you that you are not alone. Subscribe now on Spotify, Apple Podcasts, YouTube, or your favorite podcast platform.Sponsor: This episode is brought to you by On the Other Side. Thank you for your support!Hosted, Produced, Written, and Edited by: Talaya DendyDisclaimer: The information on this podcast is for general informational purposes only and SHOULD NOT be used as a substitute for sound professional medical advice, evaluation, or care from your physician or other qualified health care provider.Hosted by Ausha. See ausha.co/privacy-policy for more information.

If you have a friend or family member diagnosed with cancer or another serious illness, all you want to do is help. But where do you start? What if you say the wrong thing or don't show up in the right ways? In this episode, we go over different ways to offer support. No matter what your strengths are, we have ideas to get you started.Sign up for our newsletter series on credit card debt.  Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

If you have a friend or family member diagnosed with cancer or another serious illness, all you want to do is help. But where do you start? What if you say the wrong thing or don't show up in the right ways? In this episode, we go over different ways to offer support. No matter what your strengths are, we have ideas to get you started.Sign up for our newsletter series on credit card debt.  Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Today, Ivelisse welcomes Dr. Francisco Contreras, renowned surgical oncologist and Director, President, and Chairman of Oasis of Hope Hospital. Together, they dive into the world of integrative cancer care with a special focus on ozone therapy—a treatment that improves oxygenation, supports immune function, and works alongside conventional therapies to enhance healing outcomes.Dr. Contreras shares how ozone therapy is administered, its unique benefits, and compelling patient success stories that highlight its role in strengthening the body during cancer treatment. He also opens up about the broader philosophy of Oasis of Hope, which bridges conventional and complementary medicine to provide individualized and compassionate cancer care.Beyond the science, Dr. Contreras emphasizes the surprising yet critical connection between happiness and health, and he and Ivelisse explore how cultivating joy can impact recovery. The conversation also touches on the limitations of traditional U.S. cancer treatments and how Oasis of Hope offers a more holistic, patient-centered path.Listeners will walk away with practical insights into how ozone therapy can boost healing, strengthen the immune system, and fit into a broader integrative approach to cancer care.Learn more about Dr. Francisco Contreras and Oasis of Hope:https://www.oasisofhope.com/Suggested Resources:Ozone Treatments at Oasis of HopeOasis of Hope ExperienceBOOK:  The Art and Science of Undermining CancerBOOK:  Beating Cancer: 20 Natural, Spiritual and Medicinal RemediesOzone Oil/Cream Send us Fan Mail! Click here >Your donations power our podcast's mission to support cancer patients with hope, insights, and resources. Every contribution fuels our ability to uplift and empower. Join us in making a lasting impact. Donate now!

Pennsylvania Governor Josh Shapiro is expanding on his promise to preserve vaccine access across the commonwealth… after a reversal on recommendations from the federal government. Pennsylvania researchers are pushing back against the recent announcement from the White House of a direct link between autism and the use of the painkiller acetaminophen, the active ingredient in Tylenol. Researchers at the University of Pennsylvania are exploring a treatment that uses a patient’s own body in a surprising way to fight cancer. CAR T-Cell Therapy: A Breakthrough in Cancer Treatment and the Path Ahead | The Spark House lawmakers approved background checks to purchase any type of firearm in Pennsylvania. The proposal faces long odds of passing the state Senate. Property owners in Pennsylvania who are worried about landslides and sinkholes may soon be able to breathe easier, after the state House voted to create a state-backed insurance program to cover them. As the federal government shutdown enters its third day, access to 400 National Park Service sites is varying on a park-by-park basis. Here in Central Pennsylvania, the Gettysburg National Military Park Museum and Visitor Center is remaining open and maintaining its regular hours for visitors. It's a different scene in Philadelphia. Thirty-three Pennsylvania counties will elect a sheriff on November 4th. And Lancaster is named to the list of "best small cities in America" as determined by WalletHub. Public media's federal funding has been revoked. Your support is now more vital than ever. Help power the independent journalism and trusted programming you find on WITF by making a gift of support now at www.witf.org/givenow.Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

It is essential for adolescents and young adults (AYAs) to have a foundation of care prior to discharge after their cancer treatment, and the multidisciplinary care team, including primary care providers (PCPs), must be equipped to support these patients. In this episode, CANCER BUZZ speaks with Scott J. Capozza, PT, MSPT, on his journey navigating care after cancer treatment as a young adult and his ASCO JCO Oncology Practice article, “Patient is Otherwise Healthy.” CANCER BUZZ then speaks with Melody Griffith, MSW, LMSW, Outpatient Adolescent and Young Adult (AYA) Oncology social worker at Mayo Clinic Arizona, on her role in patient navigation and how her department supports AYAs through their entire cancer continuum. CANCER BUZZ concludes with Cathy Lee-Miller, MD, director of AYA Oncology Clinic at the University of Wisconsin Carbone Cancer Center, on their cohort training program preparing PCPs for managing AYA survivorship care.    “The late effects for young adults are very real and a lot of times they are not recognized because we look otherwise healthy on the outside, but that belies what's going on internally.” - Scott J. Capozza, PT, MSPT   “We talk about post-traumatic stress, but also post-traumatic growth and what they bring with them and what they've learned through their process. It's not just the treatment, right? After treatment, there's a lot of years left to live.” - Melody Griffith, MSW, LMSW   “We really try and help empower these patients, particularly AYAs who maybe relied on their parents for their medical care before... We really try to spell that out for people so they can take responsibility and take charge of their own long-term health.” - Cathy Lee-Miller, MD   Scott J. Capozza, PT, MSPT Board Certified Clinical Specialist in Oncologic Physical Therapy  YNHH Outpatient Oncology Rehabilitation Services Smilow Cancer Hospital Adult Cancer Survivorship Clinic New Haven, CT   Melody Griffith, MSW, LMSW Outpatient Adolescent and Young Adult (AYA) Oncology Social Worker Mayo Clinic Arizona Phoenix, AZ   Cathy Lee-Miller, MD Director, AYA Oncology Clinic Associate Professor, Pediatric Hematology/Oncology/Transplant & Cellular Therapy University of Wisconsin Carbone Cancer Center Madison, WI    This podcast is part of the AYA Oncology Screening and Survivorship Services program, made possible through the support from The Arizona Clinical Oncology Society, Indiana Oncology Society, and Wisconsin Association of Hematology and Oncology. Resources: The Arizona Clinical Oncology Society: https://tacos.accc-cancer.org/resources/adolescent-and-young-adult-cancer-resources Indiana Oncology Society: https://inos.accc-cancer.org/resources/aya-cancer-resources Wisconsin Association of Hematology and Oncology: https://waho.accc-cancer.org/resources/adolescent-and-young-adult-cancer-resources

In this episode of the Revenue Builders Podcast, our hosts John Kaplan and John McMahon are joined by Steve Garraty, a tech sales leader and author who shares his inspiring journey from a troubled teen diagnosed with cancer to a successful career in sales leadership. Steve delves into his incredible story of resilience, how he overcame a devastating cancer diagnosis at 18, and how this battle shaped his personal and professional life. Highlighting key themes of gratitude, empathy, and the power of positive thinking, Steve discusses the impact of cancer on his leadership style and offers valuable advice for those facing personal challenges. The conversation also touches on the importance of relationships and knowing one's story. Steve's newly released book, Greatfruit, captures these life-changing experiences and provides further insights into his journey.ADDITIONAL RESOURCESConnect with Steve Garraty: https://www.linkedin.com/in/stevegarratyGet Greatfruit at Barnes & Noble: https://www.barnesandnoble.com/w/greatfruit-steve-garraty/1147081359 Get Greatfruit on Amazon: https://a.co/d/2sWFNEwExplore Force Management's Free SKO Planning Resources: https://hubs.li/Q03K94cs0Read the Guide on Six Critical Priorities for Revenue Leadership in 2026: https://hubs.li/Q03JN74V0Watch Force Management's Panel Discussion on Growth, Valuation and Execution: https://bit.ly/4p6kyGSEnjoying the podcast? Sign up to receive new episodes straight to your inbox: https://hubs.li/Q02R10xN0HERE ARE SOME KEY SECTIONS TO CHECK OUT[00:01:13] Steve's Early Life and Cancer Diagnosis[00:01:39] The Battle with Cancer[00:02:02] Life After Cancer: Career and Family[00:03:04] Writing 'Great Fruit' and Reconnecting with John[00:08:08] Steve's Journey Through Chemotherapy[00:10:21] The Mental and Physical Toll of Cancer Treatment[00:22:08] Finding Blessings Amidst Tragedy[00:26:33] The Importance of Relationships and Leadership[00:34:49] The Brutal Interview Process[00:36:02] Revealing the Cancer Story[00:39:17] Writing the Book: A 37-Year Journey[00:46:58] Mindset and Health: The Power of Positive Thinking[00:54:19] Impact on Sales Career and Leadership[00:57:39] Advice for Overcoming Personal ChallengesHIGHLIGHT QUOTES[00:01:48] “He went from victim to Victor, from asking ‘Why me?' to ‘Why not me?'”[00:21:32] “Blessings can be found amidst the tragedies.”[00:25:11] “Every day is a gift.”[00:26:20] “You never know what people are going through—everybody's got a story.”[00:27:51] “The greatest sign of leadership is when your people don't need you anymore.”[01:00:48] “If you're going through something tough, the worst thing you can do is isolate.”[01:01:14] “Just show up. You don't have to say anything.”[00:27:09] “I want to help people achieve success—not for me, but for them.”[00:25:36] “Perspective is what turns adversity into a blessing.” Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

When someone finishes a cancer treatment, it can feel like the end of the story. For many, it may just be the beginning–risk of recurrence looms, long-term medications (and their side effects) begin, and it’s hard to get your bearings. What do you really need to know?In this candid conversation, Katie sits down with Dr. Lillian Smyth, Senior Vice President and Global Development Head for Breast Cancer at Eli Lilly and Company, and LaShae Rolle, a breast cancer survivor, public health researcher, and powerlifter. Together, they explore what life after breast cancer treatment really looks like: from follow-up care and managing side effects to navigating fears about recurrence and finding strength in advocacy.This episode—created in partnership with Eli Lilly—is about more than medicine. It’s about empowerment: knowing your “normal,” asking the right questions, and embracing life following cancer treatment.See omnystudio.com/listener for privacy information.

As lawmakers trade blame for the government shutdown, the economy is feeling the impact. Thousands of federal workers have been furloughed with firings potentially on the way. National Guard troops have been sent to Memphis. We have an update on twin hurricanes Imedla and Humberto. Plus, the Trump administration's initiative to end childhood cancer with AI. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Dr. Nicole Paulk is the CEO, Founder, and President of Siren Biotechnology and has dedicated her career to advancing the field of gene therapy. With nearly two decades of expertise, Nicole has been at the forefront of developing cutting-edge advances to propel the field of gene therapy forward for a wide range of diseases. Nicole has held various leadership positions in academia and industry and most notably was an Assistant Professor of AAV Gene Therapy in the UCSF Department of Biochemistry & Biophysics before leaving to found Siren. Nicole has a B.S. in Medical Microbiology, a Ph.D. in Viral Gene Therapy and Regenerative Medicine from OHSU and completed her Postdoctoral Fellowship and Instructorship in Human Gene Therapy at Stanford University prior to starting her lab at UCSF. Nicole is a pioneer in the development of next-generation AAV platforms for gene repair, gene transfer and gene editing, directed evolution for novel engineered capsid evolution, and comparative multi-omic approaches to interrogate translational AAV biology.